Ftse Mib
35.390,52
-0,06%
DAX
18.704,42
-0,11%
S&P 500
5.298,70
0,03%
NASDAQ
16.670,82
-0,16%
Bitcoin
66.702,03
2,24%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Orchard Therapeutics PLC (ORTX) Orchard Therapeutics PLC (ORTX) Notizie

Orchard Therapeutics PLC

ORTX
16,70
0,00 (0,00%)
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/5/202413:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
03/5/202413:00GLOBEOrchard Therapeutics Co-founder and Chief Executive Officer..
20/3/202412:00GLOBEOrchard Therapeutics Outlines U.S. Launch Plans for..
18/3/202420:41GLOBEOrchard Therapeutics Receives FDA Approval of Lenmeldy™..
15/2/202403:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/2/202420:39EDGAR2Form 15-12G - Securities registration termination [Section..
05/2/202413:00GLOBEOrchard Therapeutics Announces First Patient Randomized in..
02/2/202413:00GLOBEOrchard Therapeutics Announces Multiple Presentations at the..
31/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
25/1/202413:00GLOBEOrchard Therapeutics Announces Agreement with the Beneluxa..
24/1/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:41EDGAR2Form S-8 POS - Securities to be offered to employees in..
24/1/202422:28EDGAR2Form POS AM - Post-Effective amendments for registration..
24/1/202422:17EDGAR2Form 8-K - Current report
24/1/202411:00GLOBEKyowa Kirin successfully completes acquisition of Orchard..
22/1/202422:10EDGAR2Form 8-K - Current report
19/12/202322:49EDGAR2Form 8-K - Current report
11/12/202313:00GLOBEOrchard Therapeutics Receives Swissmedic Approval for..
08/12/202322:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/12/202322:37EDGAR2Form 8-K - Current report
30/11/202322:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/11/202322:06EDGAR2Form 8-K - Current report
30/11/202313:00GLOBEOrchard Therapeutics Receives U.S. FDA Fast Track..
21/11/202313:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/11/202313:51EDGAR2Form 8-K - Current report
16/11/202322:45EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
13/11/202313:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:05EDGAR2Form 8-K - Current report
13/11/202313:00GLOBEOrchard Therapeutics Reports Third Quarter 2023 Financial..
03/11/202322:11EDGAR2Form PREM14A - Preliminary proxy statements relating to..
26/10/202322:35EDGAR2Form 8-K - Current report
26/10/202313:00GLOBEOrchard Therapeutics Announces Presentation of Additional..
24/10/202313:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
17/10/202322:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/10/202323:26EDGAR2Form DEFA14C - Additional information statement materials,..
05/10/202322:48EDGAR2Form DEFA14C - Additional information statement materials,..
05/10/202322:45EDGAR2Form DEFA14C - Additional information statement materials,..
05/10/202322:43EDGAR2Form DEFA14C - Additional information statement materials,..
05/10/202322:40EDGAR2Form DEFA14C - Additional information statement materials,..
05/10/202315:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/10/202315:05EDGAR2Form 8-K - Current report
05/10/202313:19IHMARKETNEWSThursday’s Wall Street Highlights: Orchard Therapeutics,..
05/10/202309:35GLOBEKyowa Kirin to Acquire Orchard Therapeutics
18/9/202313:07EDGAR2Form 8-K - Current report
18/9/202313:00GLOBEOrchard Therapeutics Announces Acceptance of Biologics..
31/8/202313:00GLOBEOrchard Therapeutics Announces Presentation of Data..
21/8/202322:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/8/202323:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
Apertura: Min: Max:
Chiusura: 16,70

La tua Cronologia

NASDAQ
ORTX
Orchard Therapeutics
EU
BE6312949926
ACCOFORM NV 3.75% Due 25...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network